Neuropsychological assessment of cognitive functions in multiple sclerosis (MS) is increasingly considered as an important paraclinical marker of disease stability or progression in MS. Recent recommendations pro-posed an annual screening of cognitive functions in all MS patients as a standard of neuropsychological monitoring in MS. There is a clear trend to diagnose possible disease progression as early as possible, to be able to respond quickly. The theoretical part of this thesis presents the current state of knowledge on cognitive impairment in MS, its correlates, predictors, and treatment possibilities. In addition, a comprehensive overview of the neuropsychological assessment and the diagnosis of cognitive deterioration in MS is prese...
Cognitive impairment can emerge in the earliest phases of multiple sclerosis. It strongly impacts di...
Accès restreint aux membres de l'Université de Lorraine jusqu'au 2040-12-31The main objectives of th...
Objectives: Cognitive impairment can be demonstrated in 40 to 65% of MS patients, starting from earl...
Neuropsychological assessment of cognitive functions in multiple sclerosis (MS) is increasingly cons...
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system that generates...
Multiple sclerosis (MS) is a neuroinflammatory, potentially disabling demyelinating disease of the c...
Multiple sclerosis; Neurophysiological monitoring; Neuropsychological testsEsclerosi múltiple; Monit...
Background: Cognitive dysfunction appears all through the course of multiple sclerosis (MS). Mild an...
Aim: to identify the degree of cognitive impairment (CN) and to optimize the treatment of patients w...
Cognitive decline is recognized as a prevalent and debilitating symptom of multiple sclerosis (MS), ...
This thesis deals with multiple sclerosis disease and its connection with cognitive functions. The t...
Uvod: Kognitivni poremećaji kod bolesnika sa multiplom sklerozom (MS) se javljaju u 43 -72%. Cilj na...
Cognitive impairment (CI) has a prevalence of 45-70% in people with multiple sclerosis (MS), produci...
Multipla skleroza (MS) je hronično inflamatorno i neurodegenerativno oboljenje centralnog nervnog si...
Praca prezentuje tematykę badań neuropsychologicznych z zakresu funkcjonowania poznawczego i jego zw...
Cognitive impairment can emerge in the earliest phases of multiple sclerosis. It strongly impacts di...
Accès restreint aux membres de l'Université de Lorraine jusqu'au 2040-12-31The main objectives of th...
Objectives: Cognitive impairment can be demonstrated in 40 to 65% of MS patients, starting from earl...
Neuropsychological assessment of cognitive functions in multiple sclerosis (MS) is increasingly cons...
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system that generates...
Multiple sclerosis (MS) is a neuroinflammatory, potentially disabling demyelinating disease of the c...
Multiple sclerosis; Neurophysiological monitoring; Neuropsychological testsEsclerosi múltiple; Monit...
Background: Cognitive dysfunction appears all through the course of multiple sclerosis (MS). Mild an...
Aim: to identify the degree of cognitive impairment (CN) and to optimize the treatment of patients w...
Cognitive decline is recognized as a prevalent and debilitating symptom of multiple sclerosis (MS), ...
This thesis deals with multiple sclerosis disease and its connection with cognitive functions. The t...
Uvod: Kognitivni poremećaji kod bolesnika sa multiplom sklerozom (MS) se javljaju u 43 -72%. Cilj na...
Cognitive impairment (CI) has a prevalence of 45-70% in people with multiple sclerosis (MS), produci...
Multipla skleroza (MS) je hronično inflamatorno i neurodegenerativno oboljenje centralnog nervnog si...
Praca prezentuje tematykę badań neuropsychologicznych z zakresu funkcjonowania poznawczego i jego zw...
Cognitive impairment can emerge in the earliest phases of multiple sclerosis. It strongly impacts di...
Accès restreint aux membres de l'Université de Lorraine jusqu'au 2040-12-31The main objectives of th...
Objectives: Cognitive impairment can be demonstrated in 40 to 65% of MS patients, starting from earl...